{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T12:33:03Z","timestamp":1765369983067},"reference-count":39,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,5,2]]},"DOI":"10.7759\/cureus.24676","type":"journal-article","created":{"date-parts":[[2022,5,2]],"date-time":"2022-05-02T18:16:56Z","timestamp":1651515416000},"source":"Crossref","is-referenced-by-count":7,"title":["Diagnosis and Pathogenesis of Sarcopenia in Chronic Liver Disease Using Liver Magnetic Resonance Imaging"],"prefix":"10.7759","author":[{"given":"Atsushi","family":"Nakamura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsubasa","family":"Yoshimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomomi","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Ichikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/hepr.13678","article-title":"Evidence-based clinical practice guidelines for liver cirrhosis 2020","volume":"51","author":"Yoshiji H","year":"2021","unstructured":"Yoshiji H, Nagoshi S, Akahane T, et al.. Evidence-based clinical practice guidelines for liver cirrhosis 2020. Hepatol Res. 2021, 51:725-49. 10.1111\/hepr.13678","journal-title":"Hepatol Res"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2018.06.024","article-title":"EASL Clinical Practice Guidelines on nutrition in chronic liver disease","volume":"70","year":"2019","unstructured":"EASL Clinical Practice Guidelines on nutrition in chronic liver disease. J Hepatol. 2019, 70.172-93. 10.1016\/j.jhep.2018.06.024","journal-title":"J Hepatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2020.09.001","article-title":"ESPEN practical guideline: clinical nutrition in liver disease","volume":"39","author":"Bischoff SC","year":"2020","unstructured":"Bischoff SC, Bernal W, Dasarathy S, Merli M, Plank LD, Sch\u00fctz T, Plauth M. ESPEN practical guideline: clinical nutrition in liver disease. Clin Nutr. 2020, 39:3533-62. 10.1016\/j.clnu.2020.09.001","journal-title":"Clin Nutr"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2011.08.028","article-title":"Muscle wasting is associated with mortality in patients with cirrhosis","volume":"10","author":"Montano-Loza AJ","year":"2012","unstructured":"Montano-Loza AJ, Meza-Junco J, Prado CM, Lieffers JR, Baracos VE, Bain VG, Sawyer MB. Muscle wasting is associated with mortality in patients with cirrhosis. Clin Gastroenterol Hepatol. 2012, 10:166-73, 173.e1. 10.1016\/j.cgh.2011.08.028","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2021.766451","article-title":"Impact of sarcopenia on survival and clinical outcomes in patients with liver cirrhosis","volume":"8","author":"Topan MM","year":"2021","unstructured":"Topan MM, Sporea I, D\u0103nil\u0103 M, Popescu A, Ghiuchici AM, Lupu\u015foru R, \u015eirli R. Impact of sarcopenia on survival and clinical outcomes in patients with liver cirrhosis. Front Nutr. 2021, 8:766451. 10.3389\/fnut.2021.766451","journal-title":"Front Nutr"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/hep.32049","article-title":"Malnutrition, frailty, and sarcopenia in patients with cirrhosis: 2021 practice guidance by the American Association for the Study of Liver Diseases","volume":"74","author":"Lai JC","year":"2021","unstructured":"Lai JC, Tandon P, Bernal W, Tapper EB, Ekong U, Dasarathy S, Carey EJ. Malnutrition, frailty, and sarcopenia in patients with cirrhosis: 2021 practice guidance by the American Association for the Study of Liver Diseases. Hepatology. 2021, 74:1611-44. 10.1002\/hep.32049","journal-title":"Hepatology"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2018.08.002","article-title":"GLIM criteria for the diagnosis of malnutrition - a consensus report from the global clinical nutrition community","volume":"38","author":"Cederholm T","year":"2019","unstructured":"Cederholm T, Jensen GL, Correia MI, et al.. GLIM criteria for the diagnosis of malnutrition - a consensus report from the global clinical nutrition community. Clin Nutr. 2019, 38:1-9. 10.1016\/j.clnu.2018.08.002","journal-title":"Clin Nutr"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.14140690","article-title":"Hepatocellular carcinoma: diagnostic performance of multidetector CT and MR imaging-a systematic review and meta-analysis","volume":"275","author":"Lee YJ","year":"2015","unstructured":"Lee YJ, Lee JM, Lee JS, et al.. Hepatocellular carcinoma: diagnostic performance of multidetector CT and MR imaging-a systematic review and meta-analysis. Radiology. 2015, 275:97-109. 10.1148\/radiol.14140690","journal-title":"Radiology"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2018-317593","article-title":"Advances in non-invasive assessment of hepatic fibrosis","volume":"69","author":"Loomba R","year":"2020","unstructured":"Loomba R, Adams LA. Advances in non-invasive assessment of hepatic fibrosis. Gut. 2020, 69:1343-52. 10.1136\/gutjnl-2018-317593","journal-title":"Gut"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29797","article-title":"Noninvasive, quantitative assessment of liver fat by MRI-PDFF as an endpoint in NASH trials","volume":"68","author":"Caussy C","year":"2018","unstructured":"Caussy C, Reeder SB, Sirlin CB, Loomba R. Noninvasive, quantitative assessment of liver fat by MRI-PDFF as an endpoint in NASH trials. Hepatology. 2018, 68:763-72. 10.1002\/hep.29797","journal-title":"Hepatology"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29602","article-title":"Fat-free muscle mass in magnetic resonance imaging predicts acute-on-chronic liver failure and survival in decompensated cirrhosis","volume":"67","author":"Praktiknjo M","year":"2018","unstructured":"Praktiknjo M, Book M, Luetkens J, et al.. Fat-free muscle mass in magnetic resonance imaging predicts acute-on-chronic liver failure and survival in decompensated cirrhosis. Hepatology. 2018, 67:1014-26. 10.1002\/hep.29602","journal-title":"Hepatology"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/apt.15927","article-title":"Review article: prognostic significance of body composition abnormalities in patients with cirrhosis","volume":"52","author":"Ebadi M","year":"2020","unstructured":"Ebadi M, Bhanji RA, Tandon P, Mazurak V, Baracos VE, Montano-Loza AJ. Review article: prognostic significance of body composition abnormalities in patients with cirrhosis. Aliment Pharmacol Ther. 2020, 52:600-18. 10.1111\/apt.15927","journal-title":"Aliment Pharmacol Ther"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.15403\/jgld-3071","article-title":"Adipopenia is the rapid screening tool that best predicts mortality in patients with decompensated cirrhosis: results of a prospective study","volume":"30","author":"De Luca M","year":"2021","unstructured":"De Luca M, Addario L, Lombardi A, et al.. Adipopenia is the rapid screening tool that best predicts mortality in patients with decompensated cirrhosis: results of a prospective study. J Gastrointestin Liver Dis. 2021, 30:94-102. 10.15403\/jgld-3071","journal-title":"J Gastrointestin Liver Dis"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2017.32","article-title":"Lipid droplets and liver disease: from basic biology to clinical implications","volume":"14","author":"Gluchowski NL","year":"2017","unstructured":"Gluchowski NL, Becuwe M, Walther TC, Farese RV Jr. Lipid droplets and liver disease: from basic biology to clinical implications. Nat Rev Gastroenterol Hepatol. 2017, 14:343-55. 10.1038\/nrgastro.2017.32","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2021.105937","article-title":"Lipid droplets and their interactions with other organelles in liver diseases","volume":"133","author":"Wang L","year":"2021","unstructured":"Wang L, Liu J, Miao Z, Pan Q, Cao W. Lipid droplets and their interactions with other organelles in liver diseases. Int J Biochem Cell Biol. 2021, 133:105937. 10.1016\/j.biocel.2021.105937","journal-title":"Int J Biochem Cell Biol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.4093\/dmj.2020.0137","article-title":"Magnetic resonance-based assessments better capture pathophysiologic profiles and progression in nonalcoholic fatty liver disease","volume":"45","author":"Choi SJ","year":"2021","unstructured":"Choi SJ, Kim SM, Kim YS, et al.. Magnetic resonance-based assessments better capture pathophysiologic profiles and progression in nonalcoholic fatty liver disease. Diabetes Metab J. 2021, 45:739-52. 10.4093\/dmj.2020.0137","journal-title":"Diabetes Metab J"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2016.12.006","article-title":"Validation of intimate correlation between visceral fat and hepatic steatosis: quantitative measurement techniques using CT for area of\u00a0fat and MR for hepatic steatosis","volume":"37","author":"Choi MH","year":"2018","unstructured":"Choi MH, Choi JI, Park MY, et al.. Validation of intimate correlation between visceral fat and hepatic steatosis: quantitative measurement techniques using CT for area of\u00a0fat and MR for hepatic steatosis. Clin Nutr. 2018, 37:214-22. 10.1016\/j.clnu.2016.12.006","journal-title":"Clin Nutr"},{"key":"ref18","article-title":"[A national surveillance study on alcoholic liver disease in Japan (1986-1991)]","volume":"91","author":"Takada A","year":"1994","unstructured":"Takada A, Matsuda Y, Takase S, et al.. [A national surveillance study on alcoholic liver disease in Japan (1986-1991)]. Nihon Shokakibyo Gakkai Zasshi. 1994, 91:887-98.","journal-title":"Nihon Shokakibyo Gakkai Zasshi"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2015.11.048","article-title":"Magnetic resonance imaging more accurately classifies steatosis and fibrosis in patients with nonalcoholic fatty liver disease than transient elastography","volume":"150","author":"Imajo K","year":"2016","unstructured":"Imajo K, Kessoku T, Honda Y, et al.. Magnetic resonance imaging more accurately classifies steatosis and fibrosis in patients with nonalcoholic fatty liver disease than transient elastography. Gastroenterology. 2016, 150:626-637.e7. 10.1053\/j.gastro.2015.11.048","journal-title":"Gastroenterology"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0801209","article-title":"Hyponatremia and mortality among patients on the liver-transplant waiting list","volume":"359","author":"Kim WR","year":"2008","unstructured":"Kim WR, Biggins SW, Kremers WK, et al.. Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med. 2008, 359:1018-26. 10.1056\/NEJMoa0801209","journal-title":"N Engl J Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2007.06.012","article-title":"Assessment of hepatic fibrosis with magnetic resonance elastography","volume":"5","author":"Yin M","year":"2007","unstructured":"Yin M, Talwalkar JA, Glaser KJ, et al.. Assessment of hepatic fibrosis with magnetic resonance elastography. Clin Gastroenterol Hepatol. 2007, 5:1207-1213.e2. 10.1016\/j.cgh.2007.06.012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1002\/jmri.20831","article-title":"Water-fat separation with IDEAL gradient-echo imaging","volume":"25","author":"Reeder SB","year":"2007","unstructured":"Reeder SB, McKenzie CA, Pineda AR, et al.. Water-fat separation with IDEAL gradient-echo imaging. J Magn Reson Imaging. 2007, 25:644-52. 10.1002\/jmri.20831","journal-title":"J Magn Reson Imaging"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2018.05.059","article-title":"Magnetic resonance vs transient elastography analysis of patients with nonalcoholic fatty liver disease: a systematic review and pooled analysis of individual participants","volume":"17","author":"Hsu C","year":"2019","unstructured":"Hsu C, Caussy C, Imajo K, et al.. Magnetic resonance vs transient elastography analysis of patients with nonalcoholic fatty liver disease: a systematic review and pooled analysis of individual participants. Clin Gastroenterol Hepatol. 2019, 17:630-7.e8. 10.1016\/j.cgh.2018.05.059","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1002\/jmri.25868","article-title":"Magnetic resonance elastography is as accurate as liver biopsy for liver fibrosis staging","volume":"47","author":"Morisaka H","year":"2018","unstructured":"Morisaka H, Motosugi U, Ichikawa S, et al.. Magnetic resonance elastography is as accurate as liver biopsy for liver fibrosis staging. J Magn Reson Imaging. 2018, 47:1268-75. 10.1002\/jmri.25868","journal-title":"J Magn Reson Imaging"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i25.8061","article-title":"Clinical relevance of sarcopenia in patients with cirrhosis","volume":"20","author":"Montano-Loza AJ","year":"2014","unstructured":"Montano-Loza AJ. Clinical relevance of sarcopenia in patients with cirrhosis. World J Gastroenterol. 2014, 20:8061-71. 10.3748\/wjg.v20.i25.8061","journal-title":"World J Gastroenterol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2020.108889","article-title":"Yttrium-90 radioembolization for hepatocellular carcinoma: outcome prediction with MRI derived fat-free muscle area","volume":"125","author":"Faron A","year":"2020","unstructured":"Faron A, Sprinkart AM, Pieper CC, et al.. Yttrium-90 radioembolization for hepatocellular carcinoma: outcome prediction with MRI derived fat-free muscle area. Eur J Radiol. 2020, 125:108889. 10.1016\/j.ejrad.2020.108889","journal-title":"Eur J Radiol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1007\/s00270-021-02874-6","article-title":"MRI-derived sarcopenia associated with increased mortality following yttrium-90 radioembolization of hepatocellular carcinoma","volume":"44","author":"Guichet PL","year":"2021","unstructured":"Guichet PL, Taslakian B, Zhan C, et al.. MRI-derived sarcopenia associated with increased mortality following yttrium-90 radioembolization of hepatocellular carcinoma. Cardiovasc Intervent Radiol. 2021, 44:1561-9. 10.1007\/s00270-021-02874-6","journal-title":"Cardiovasc Intervent Radiol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-29825-5","article-title":"Skeletal muscle cutoff values for sarcopenia diagnosis using T10 to L5 measurements in a healthy US population","volume":"8","author":"Derstine BA","year":"2018","unstructured":"Derstine BA, Holcombe SA, Ross BE, Wang NC, Su GL, Wang SC. Skeletal muscle cutoff values for sarcopenia diagnosis using T10 to L5 measurements in a healthy US population. Sci Rep. 2018, 8:11369. 10.1038\/s41598-018-29825-5","journal-title":"Sci Rep"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.12869","article-title":"Sarcopenia as a prognostic indicator of liver cirrhosis","volume":"13","author":"Kim SE","year":"2022","unstructured":"Kim SE, Kim DJ. Sarcopenia as a prognostic indicator of liver cirrhosis. J Cachexia Sarcopenia Muscle. 2022, 13:8-10. 10.1002\/jcsm.12869","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v27.i29.4862","article-title":"Muscular abnormalities in liver cirrhosis","volume":"27","author":"Hari A","year":"2021","unstructured":"Hari A. Muscular abnormalities in liver cirrhosis. World J Gastroenterol. 2021, 27:4862-78. 10.3748\/wjg.v27.i29.4862","journal-title":"World J Gastroenterol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.11.006","article-title":"Effect of sarcopenia on survival in patients with cirrhosis: a meta-analysis","volume":"76","author":"Tantai X","year":"2022","unstructured":"Tantai X, Liu Y, Yeo YH, et al.. Effect of sarcopenia on survival in patients with cirrhosis: a meta-analysis. J Hepatol. 2022, 76:588-99. 10.1016\/j.jhep.2021.11.006","journal-title":"J Hepatol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13143593","article-title":"Accelerated T2-weighted TSE imaging of the prostate using deep learning image reconstruction: a prospective comparison with standard T2-weighted TSE imaging","volume":"13","author":"Gassenmaier S","year":"2021","unstructured":"Gassenmaier S, Afat S, Nickel MD, et al.. Accelerated T2-weighted TSE imaging of the prostate using deep learning image reconstruction: a prospective comparison with standard T2-weighted TSE imaging. Cancers (Basel). 2021, 13:3593. 10.3390\/cancers13143593","journal-title":"Cancers (Basel)"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2021.02.036","article-title":"Noncontrast MRI for hepatocellular carcinoma detection: a systematic review and meta-analysis - a potential surveillance tool?","volume":"20","author":"Chan MV","year":"2022","unstructured":"Chan MV, Huo YR, Trieu N, et al.. Noncontrast MRI for hepatocellular carcinoma detection: a systematic review and meta-analysis - a potential surveillance tool?. Clin Gastroenterol Hepatol. 2022, 20:44-56.e2. 10.1016\/j.cgh.2021.02.036","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1111\/liv.14175","article-title":"Adipopenia correlates with higher portal pressure in patients with cirrhosis","volume":"39","author":"Rodrigues SG","year":"2019","unstructured":"Rodrigues SG, Brabandt B, Stirnimann G, Maurer MH, Berzigotti A. Adipopenia correlates with higher portal pressure in patients with cirrhosis. Liver Int. 2019, 39:1672-81. 10.1111\/liv.14175","journal-title":"Liver Int"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/s0899-9007(01)00754-7","article-title":"Prognostic value of energy metabolism in patients with viral liver cirrhosis","volume":"18","author":"Tajika M","year":"2002","unstructured":"Tajika M, Kato M, Mohri H, Miwa Y, Kato T, Ohnishi H, Moriwaki H. Prognostic value of energy metabolism in patients with viral liver cirrhosis. Nutrition. 2002, 18:229-34. 10.1016\/s0899-9007(01)00754-7","journal-title":"Nutrition"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1152\/japplphysiol.01042.2012","article-title":"Sarcopenia and a physiologically low respiratory quotient in patients with cirrhosis: a prospective controlled study","volume":"114","author":"Glass C","year":"2013","unstructured":"Glass C, Hipskind P, Tsien C, et al.. Sarcopenia and a physiologically low respiratory quotient in patients with cirrhosis: a prospective controlled study. J Appl Physiol (1985). 2013, 114:559-65. 10.1152\/japplphysiol.01042.2012","journal-title":"J Appl Physiol (1985)"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22367","article-title":"Nocturnal nutritional supplementation improves total body protein status of patients with liver cirrhosis: a randomized 12-month trial","volume":"48","author":"Plank LD","year":"2008","unstructured":"Plank LD, Gane EJ, Peng S, et al.. Nocturnal nutritional supplementation improves total body protein status of patients with liver cirrhosis: a randomized 12-month trial. Hepatology. 2008, 48:557-66. 10.1002\/hep.22367","journal-title":"Hepatology"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7693","article-title":"A muscle-liver-fat signalling axis is essential for central control of adaptive adipose remodelling","volume":"6","author":"Shimizu N","year":"2015","unstructured":"Shimizu N, Maruyama T, Yoshikawa N, et al.. A muscle-liver-fat signalling axis is essential for central control of adaptive adipose remodelling. Nat Commun. 2015, 6:6693. 10.1038\/ncomms7693","journal-title":"Nat Commun"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-019-01633-2","article-title":"Hepatic FATP5 expression is associated with histological progression and loss of hepatic fat in NAFLD patients","volume":"55","author":"Enooku K","year":"2020","unstructured":"Enooku K, Tsutsumi T, Kondo M, et al.. Hepatic FATP5 expression is associated with histological progression and loss of hepatic fat in NAFLD patients. J Gastroenterol. 2020, 55:227-43. 10.1007\/s00535-019-01633-2","journal-title":"J Gastroenterol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/75294-diagnosis-and-pathogenesis-of-sarcopenia-in-chronic-liver-disease-using-liver-magnetic-resonance-imaging","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:38:24Z","timestamp":1707507504000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/75294-diagnosis-and-pathogenesis-of-sarcopenia-in-chronic-liver-disease-using-liver-magnetic-resonance-imaging"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,2]]},"references-count":39,"URL":"https:\/\/doi.org\/10.7759\/cureus.24676","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5,2]]}}}